Why the study?
Hemodynamic force analysis has been proposed as a novel tool for early detection of subclinical systolic dysfunction in HFpEF, but its ability to discriminate healthy subjects from heart failure patients with varying systolic dysfunction required investigation.
Does hemodynamic force analysis using cardiac magnetic resonance discriminate between healthy subjects and HFpEF patients?
Does hemodynamic force analysis using cardiac magnetic resonance discriminate between healthy subjects and HFpEF patients?
Hemodynamic force analysis using cardiac magnetic resonance does not differentiate between healthy controls and HFpEF patients, suggesting it is not ready for clinical trials in HFpEF assessment.
Authors
No takes yet. Share an insight, caveat, or question.
CMR hemodynamic forces lack discriminatory value in HFpEF; leaves open prospective validation for HFrEF phenotyping.
Arvidsson et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: